My husband, Billy, loves to golf. After working hard all week, there is nothing he enjoys more than spending a few hours on the golf course. These days, I don’t mind how much time he spends golfing. In fact, I encourage it. But it wasn’t always that way. When our…
Discussion
All 12 girls and women with Rett syndrome given the gene therapy candidate TSHA-102 in a clinical trial gained or regained at least one developmental milestone within one year, with consistent responses seen across differing ages and disease severity levels, new trial data show. Longer-term follow‑up data from Part…
Discussion
There aren’t many doctors who specialize in Rett syndrome, my daughter Abby’s disability, and so earlier this year when we got word that Dr. Sasha was retiring, it was quite a blow to our household. Not only had she long been a steady hand in Abby’s caregiving circle, but…
Discussion
All 25 participants in the Phase 3 Embolden study have received their doses of NGN-401, Neurogene’s experimental gene therapy for Rett syndrome, surpassing the trial’s initial enrollment target ahead of schedule. “We are pleased to have completed dosing in the Embolden trial of NGN-401 within our original timeline while…
Rett syndrome is a rare genetic disorder that mostly affects females. The disease is characterized by normal early development, followed by slowed growth and a loss of motor control. Learn more about the disease here.
Most cases are caused by a mutation in the MECP2 gene. Scientists have identified mutations in CDKL5 and FOXG1 genes in those who have atypical or congenital Rett. Learn more about what causes the disease here.
Rett syndrome is associated with problems in cognitive, sensory, emotional, and motor skills, and across the nervous system that controls involuntary (or autonomic) functions. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
